(BBIO) – Analyst Comments
-
Raymond James Resumes BridgeBio Pharma (BBIO) at Outperform, 'Well Positioned'
-
BridgeBio Pharma (BBIO) PT Raised to $45 at JPMorgan
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BBIO Stock Lookup